The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

An expert discusses how key symptoms of narcolepsy, such as excessive daytime sleepiness and cataplexy, impact daily functioning and quality of life, along with the primary differences between type 1 ...

Capital Rx, a pharmacy benefit manager and administrator, has announced Judi Health, the first centralized claims processing ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

“We can point to situations where prior authorization has literally saved lives. There are good docs and there are bad docs ...

A panelist discusses how the potential of neurokinin-targeted therapies to provide targeted symptom relief with fewer side effects represents a significant advancement in menopause care while noting ...

A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or ...

The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...

Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...

Laurie Ratliff was diagnosed with metastatic breast cancer 25 years ago, and she’s continuing to beat the odds while ...

The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...